Subscribe to Search results

Hemofil was given to one child as part of the study; he did not bleed frequently and so needed only limited treatment, but went on to develop acute hepatitis.

Published on:

Dr Kirk wrote to parents of a student at Treloar's to inform them their son had been "selected to receive only Kryobulin when he requires transfusing. By limiting him to this type of factor VIII containing material it will be easier to trace the source should he contract hepatitis."

Published on:

A letter about a Treloar's pupil written to his home clinician showed that there had been no advance discussion about the research on him.

Published on:

Dr Kirk proposed to restrict patients to either commercial concentrates as a group or cryoprecipitate or Lister Concentrate as part of the next stage of a hepatitis study.

Published on:

Dr Craske from the Public Health Laboratory Service encouraged further study of hepatitis associated with the use of commercial Factor 8.

Published on:

Dr Craske encouraged further research and applied for a research grant on hepatitis associated with the use of commercial Factor 8.

Published on:

There was a trial to see which of three dosage regimes addressed bleeds into knee, elbow and ankle joints most effectively. This involved pupils being given doses of 7, 14, or 28 units (per kilogram of their bodyweight), and was written up in The Lancet.

Published on:

A report of a trial stated that there was "growing evidence that chronic hepatitis was a not-uncommon consequence of transfusion", related to the total number of donors to whose blood a patient had been exposed.

Published on:

Dr Aronstam informed the Treloar's students about AIDs and said the risk was "very small".

Published on:

In late 1984, Treloar clinicians told pupils that HIV infections were an unavoidable accident.

Published on:

Gary Bennett, a student at Treloar's, was put on "long term prophylaxis" for which three different types of concentrate were used.

Published on:

Dr Morag Chisholm protested to Dr Aronstam "many times" that she did not want concentrate used on patients, but was told it was needed.

Published on:

Gary Bennett, a student at Treloar's, was one of seven pupils put on a trial of DDAVP.

Published on:

The parents of Gary Bennett, a Treloar's student, were not informed of the DDVAP trial.

Published on:

John Peach, parent of a student at Treloar's, was never told that his son was being given commercial concentrate.

Published on:

John Peach, parent of a student at Treloar's, was not told that prophylaxis was trialled on his son.

Published on:

John Peach, parent of a student at Treloar's, was not told as soon as his son developed hepatitis.

Published on:

Jason Peach, a student at Treloar's, was treated with commercial concentrate without his parents' knowledge and without them being informed of risk. The parents were only made aware of the possibility of their child going "yellow" with "a bit of jaundice", which they understood to be both mild and unavoidable.

Published on:

Nick Sainsbury remembered the Headmaster at Treloar's, Mr Macpherson, telling students not to worry hepatitis because they had the mild type.

Published on:

Jason Peach, a student at Treloar's, was never told by Treloar's school of his infections and instead he learned via his home centre, the Oxford Haemophilia Centre.

Published on: